Clinical Trials on CLL (Chronic Lymphocytic Leukemia)
Total 37311 results
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia (CLL)United States, France, Italy, Poland, Canada, Israel, Germany, Belgium
-
Gilead SciencesApproved for marketingChronic Lymphocytic Leukemia (CLL)United States, Italy, United Kingdom, Ireland
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Northwell HealthTerminated
-
CytRxCompletedB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Cylene PharmaceuticalsWithdrawnB-Cell Chronic Lymphocytic LeukemiaUnited States
-
AstraZenecaActive, not recruitingChronic Lymphocytic Leukemia or Small Lymphocytic LymphomaSpain, United States, Australia, France, Czechia, Hungary, Poland
-
SanofiCompletedLeukemia, Lymphocytic, ChronicBelgium, United States, Australia, France, Germany, Italy, Netherlands, Puerto Rico, United Kingdom
-
AbbVieTerminatedChronic Lymphocytic Leukemia (CLL)Russian Federation
-
Pharmacyclics LLC.Janssen, LPCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Gilead SciencesBoehringer IngelheimTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
University of PeloponneseNational and Kapodistrian University of Athens; Harokopio UniversityCompleted
-
Merck Sharp & Dohme LLCCompletedChronic Lymphocytic Leukemia (CLL)
-
BioCryst PharmaceuticalsCompletedChronic Lymphocytic Leukemia (CLL)United States, Australia
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
National Cancer Institute (NCI)TerminatedRecurrent Small Lymphocytic Lymphoma | B-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Richter Syndrome | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Hoffmann-La RocheTerminatedB-Cell Chronic Lymphocytic LeukemiaItaly, Spain, Israel, United Kingdom, Latvia
-
Prof. Dr. Med. Laimonas GriskeviciusCompletedB-Cell Chronic Lymphocytic LeukemiaLithuania
-
CelgeneCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Austria
-
CelgeneCompletedB-Cell Chronic Lymphocytic LeukemiaUnited States, Spain, Australia, Belgium, Italy, Serbia, Poland, Israel, New Zealand, Portugal, Brazil, France, Bulgaria, Croatia, Czechia, Hungary, Russian Federation, Netherlands, Romania, Denmark, United Kingdom, Austria, Canada, South... and more
-
Janssen-Cilag Farmaceutica Ltda.Approved for marketingB-cell Chronic Lymphocytic LeukemiaBrazil
-
Southwest Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
SBI Biotech Co., Ltd.Terminated
-
Genzyme, a Sanofi CompanyCompletedB-Cell Chronic Lymphocytic LeukemiaSweden, United States, Croatia, Canada, Ukraine, Austria, Bulgaria, France, Germany, Greece, Italy, Poland, Portugal, Romania, Russian Federation
-
BayerCompleted
-
BiogenTerminatedB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Chronic Lymphocytic Leukemia Research ConsortiumBayerUnknownB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Genitope CorporationTerminatedB-Cell Chronic Lymphocytic Leukemia
-
AbbVieActive, not recruitingCancer - Chronic Lymphocytic LeukemiaFrance
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedRefractory Chronic Lymphocytic LeukemiaUnited States
-
Ohio State University Comprehensive Cancer CenterAstex Pharmaceuticals, Inc.CompletedB-Chronic Lymphocytic LeukemiaUnited States
-
Steven E. CoutreCompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Karolinska University HospitalSchering Nordiska ABCompleted
-
National Cancer Institute (NCI)CompletedLeukemia | Chronic | LymphocyticUnited States
-
French Innovative Leukemia OrganisationCompletedB Cell Chronic Lymphocytic LeukemiaFrance
-
Arbeitsgemeinschaft medikamentoese TumortherapieSchering-PloughCompletedB-cell Chronic Lymphocytic LeukemiaAustria
-
US Oncology ResearchAstex Pharmaceuticals, Inc.CompletedB-Cell Chronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupUniversity of Cologne; MedacSchering OnkologieCompletedB-cell Chronic Lymphocytic LeukemiaGermany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Tawam HospitalUnknownB-Cell Chronic Lymphocytic Leukemia
-
Memorial Sloan Kettering Cancer CenterMassachusetts General Hospital; BeiGene USA, Inc.; Roche-GenentechRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Leukemia (SLL)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter Syndrome | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic LeukemiaUnited States
-
AbbVieActive, not recruitingChronic Lymphocytic Leukemia (CLL)Austria, Germany, Switzerland
-
University of RochesterActive, not recruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
-
Novartis PharmaceuticalsTerminatedRelapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Spain, United States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.TerminatedRelapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChina
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic LymphomaUnited States, Italy